Video proceedings from the fourth in a series of 6 integrated
symposia held at the 2019 ONS Annual Congress. Featuring
perspectives from Dr Paul M Barr, Ms Josie Bazemore, Dr Nitin Jain
and Ms Lynn Rich:
Introduction (0m0s)
Program overview: Dr Love
Newly Diagnosed Chronic Lymphocytic Leukemia (CLL): Observation
versus Treatment (00:38)
Case (Ms Bazemore): A woman in her early 60s with CLL with
del(17p) and an IGHV mutation who was observed for 1 year before
beginning treatment with ibrutinib (2:17)
First-Line Treatment of CLL (6:58)
Case (Ms Rich): A woman in her late 30s with newly diagnosed
CLL who received FCR and has developed multiple infections after
the completion of treatment (15:52)
Case (Ms Bazemore): A man in his early 90s with CLL with
unmutated IGHV who experienced a complete response to first-line
obinutuzumab/chlorambucil (48:40)
Relapsed/Refractory CLL (53:33)
Case (Ms Rich): A man in his early 70s with relapsed CLL and a
high tumor burden who initiated treatment with venetoclax
(1:12:24)
Case (Ms Bazemore): A man in his mid-60s with relapsed CLL who
was admitted to receive venetoclax because of concerns with
compliance (1:15:40)
Case (Ms Rich): A man in his mid-70s with heavily pretreated
CLL who was referred for hospice but is currently faring well off
treatment (1:22:09)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.